CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
50 hedge funds and large institutions have $115M invested in Crescent Biopharma, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 7 closing their positions.
Holders
50
Holders Change
+2
Holders Change %
+4.17%
% of All Funds
1.25%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
10
Increased
17
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–